Alex Kuta
Nessuna posizione attualmente
Patrimonio netto: 469 981 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Alex Kuta
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
25
| Public Company | Biotechnology | 25 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA.
6
| Subsidiary | Medical Specialties | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Alex Kuta tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer General Counsel | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Veranova LP | Chief Tech/Sci/R&D Officer | ||
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Graduate Degree | |
| University of Twente | College/University | Graduate Degree | |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University College London | College/University | Undergraduate Degree | |
| University of Utrecht | College/University | Doctorate Degree Graduate Degree | |
| University of Geneva | College/University | Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree | |
Avista Capital Holdings LP
 Avista Capital Holdings LP Investment ManagersFinance Avista Capital Holdings LP (Avista Capital Partners) is a private equity firm founded in 2005 by Steven Webster and Thompson Dean. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Founder | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Fougera Pharmaceuticals, Inc.
 Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| CG ONCOLOGY, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| LANTHEUS HOLDINGS, INC. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Chairman Chief Tech/Sci/R&D Officer | |
Bioprocess Pilot Facility BV
 Bioprocess Pilot Facility BV Miscellaneous Commercial ServicesCommercial Services Bioprocess Pilot Facility BV is a Dutch biotechnology company. The joint venture company is based in Delft, Netherlands. Eric Goossens has been the CEO of the company since 2017. | Miscellaneous Commercial Services | Chief Executive Officer | |
| European Pharmaceutical Market Research Association | Director/Board Member | ||
| Cranfield School of Management | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 35 |
| Paesi Bassi | 6 |
| Svizzera | 5 |
| Regno Unito | 4 |
| Canada | 3 |
Settori
| Health Technology | 31 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 4 |
Posizioni
| Director/Board Member | 145 |
| Corporate Officer/Principal | 131 |
| Chief Tech/Sci/R&D Officer | 59 |
| Independent Dir/Board Member | 45 |
| Undergraduate Degree | 40 |
Contatti più connessi
| Insiders | |
|---|---|
| Brian Markison | 30 |
| Leonard Post | 25 |
| Jeffrey Bailey | 21 |
| Paris Panayiotopoulos | 18 |
| David Meek | 18 |
| Sander J. van Deventer | 17 |
| Jacques Suzanne | 15 |
| Larry G. Pickering | 15 |
| David Schaffer | 15 |
| Madhavan Balachandran | 15 |
| Allene Diaz | 14 |
| Jeremy Springhorn | 14 |
| Deborah Brown | 13 |
| Steven Zelenkofske | 13 |
| Joseph Leveque | 12 |
- Borsa valori
- Insiders
- Alex Kuta
- Connessioni Società
